Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Dr. Hinrich Abken is Professor for Genetics & Immunology at CMMC (Center for Molecular Medicine Cologne) at the University of Cologne and Dept I Internal Medicine, Oncology-Hematology at the University Hospital Cologne. Dr. Abken studied medicine, was post-doc at the Institute for Cell Biology (Prof Rajewsky) at Essen University, was group leader at the University of Bonn, Faculty of Sciences, and in 1993 he became University Professor for Tumor Genetics at the Medical Faculty of the University of Cologne.
Dr. Abken's group is internationally leading in pre-clinical research of adoptive therapy with T cells engineered with chimeric antigen receptors (CARs). Current research is aimed at improving T cell targeting of cancer, at developing novel strategies in modulating an immune response and at translating the T cell strategy into clinical trials.